{"key":"op_1430_TR","page":{"url":"https://ru.bookimed.com/clinics/country=turkey/procedure=lechenie-bolezni-alcgeymera-stvolovymi-kletkami/","procedure":{"id":1430,"slug":"lechenie-bolezni-alcgeymera-stvolovymi-kletkami","name":"Лечение болезни Альцгеймера стволовыми клетками","name_forms":{"plural":{"status":"missing","reason":"not_collected"},"genitive":{"status":"missing","reason":"not_collected"}},"type":"therapy","grammar_number":{"status":"missing","reason":"not_collected"},"parent_id":"stem-cells","family_attribute":{"status":"missing","reason":"not_collected"}},"country":{"id":46,"iso":"TR","name":"Турция"},"currency":"USD","data_date":"2026-10-09"},"pages":{"clinics_url":"https://ru.bookimed.com/clinics/country=turkey/procedure=lechenie-bolezni-alcgeymera-stvolovymi-kletkami/","cost_url":"https://ru.bookimed.com/clinics/country=turkey/procedure=lechenie-bolezni-alcgeymera-stvolovymi-kletkami/cost/","best_url":{"status":"missing","reason":"template not live"}},"price":{"from":11900,"to":12000,"avg":{"status":"missing","reason":"no_offers"},"us":{"from":6500,"to":14000},"uk":{"from":9500,"to":19500},"by_technique":{"status":"missing","reason":"not_collected"},"by_city":[{"city":"Стамбул","from":11900},{"city":"Анталия","from":6500},{"city":"Измир","from":6500}],"per_unit":{"status":"missing","reason":"not_collected"},"factors":{"status":"missing","reason":"not_collected"},"tiers":{"status":"missing","reason":"no_offers"},"comparison":[{"country_iso":"UA","from":11100,"to":15500},{"country_iso":"FR","from":9000,"to":18000},{"country_iso":"GB","from":9500,"to":19500},{"country_iso":"US","from":6500,"to":14000},{"country_iso":"IL","from":14000,"to":24000},{"country_iso":"MX","from":9000,"to":20000},{"country_iso":"DE","from":9000,"to":16500},{"country_iso":"CA","from":6500,"to":18000},{"country_iso":"AE","from":9000,"to":21000},{"country_iso":"TH","from":7200,"to":19000},{"country_iso":"PL","from":6500,"to":12500},{"country_iso":"KR","from":32900,"to":{"status":"missing","reason":"not_collected"}},{"country_iso":"CZ","from":6500,"to":11000},{"country_iso":"AT","from":9500,"to":15500},{"country_iso":"ES","from":6500,"to":12500},{"country_iso":"IT","from":9500,"to":17500},{"country_iso":"CN","from":15800,"to":26000},{"country_iso":"AU","from":9000,"to":19000},{"country_iso":"IN","from":6500,"to":12500},{"country_iso":"MY","from":6500,"to":13500},{"country_iso":"VN","from":9000,"to":20000},{"country_iso":"BR","from":8000,"to":12000}],"base_country":"US","base_is_fallback":false},"savings":{"pct":-83,"variant":"ranges_overlap"},"package":{"included":{"status":"missing","reason":"no_offers"},"excluded":{"status":"missing","reason":"no_offers"},"extra_charges":{"status":"missing","reason":"not_collected"}},"clinics":{"count":5,"items":[{"id":96,"name":"Memorial Şişli Hospital","city":"Istanbul","rating":4.6,"reviews_count":436,"accreditations":["International Organization for Standardization","Joint Commission International"],"rank":1,"has_procedure":true,"why_ranked":"Uses umbilical cord-derived mesenchymal stem cells (UC-MSC) at 1–2 million cells/kg per session. First JCI-accredited hospital in Turkey. Doctor with 150+ publications and 900+ procedures.","bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":410,"name":"Memorial Bahçelievler Hospital","city":"Istanbul","rating":4.6,"reviews_count":165,"accreditations":["International Organization for Standardization","Joint Commission International"],"rank":2,"has_procedure":true,"why_ranked":"Neurologist Hatice Hale Tuzun has 28 years of experience and has performed 1100+ treatments. The hospital has a 91% recommendation rate from patients.","bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":5614,"name":"VM Medical Park Pendik Hospital","city":"Istanbul","rating":3,"reviews_count":2,"accreditations":["Joint Commission International"],"rank":3,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":1900,"name":"Biruni University Hospital","city":"Istanbul","rating":{"status":"missing","reason":"not_collected"},"reviews_count":{"status":"missing","reason":"not_collected"},"accreditations":["Turkish Medical Association","TEMOS International Healthcare Accreditation"],"rank":4,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":8801,"name":"Op. Dr. Tamer Şakrak","city":"Istanbul","rating":{"status":"missing","reason":"not_collected"},"reviews_count":{"status":"missing","reason":"not_collected"},"accreditations":{"status":"missing","reason":"not_collected"},"rank":5,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}}]},"doctors":{"count":6,"languages":{"status":"missing","reason":"not_collected"}},"cities":[{"id":107,"slug":"stambul","name":"Стамбул","clinics_count":1,"price_from":11900,"profile":{"city_type":"Largest city in Turkey, megacity","access":["Sabiha Gökçen Airport (SAW), 32 km southeast of city center"],"sources":["https://en.wikipedia.org/wiki/Istanbul","https://en.wikipedia.org/wiki/Sabiha_G%C3%B6k%C3%A7en_International_Airport"],"checked_at":"2026-11-03","status":"ok"}},{"id":382,"slug":"antalia","name":"Анталия","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":6500,"profile":{"city_type":"Major Mediterranean coastal city in Turkey","access":["Antalya Airport (AYT), 13 km from the city center"],"sources":["https://en.wikipedia.org/wiki/Antalya","https://en.wikipedia.org/wiki/Antalya_Airport"],"checked_at":"2026-11-03","status":"ok"}},{"id":395,"slug":"izmir","name":"Измир","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":6500,"profile":{"city_type":"Aegean coastal port city in Turkey","access":["Izmir Airport (ADB), 14 km from the city center"],"sources":["https://en.wikipedia.org/wiki/%C4%B0zmir","https://en.wikipedia.org/wiki/Izmir_Adnan_Menderes_Airport"],"checked_at":"2026-11-03","status":"ok"}}],"offers":{"active":{"status":"missing","reason":"no_offers"},"active_with_related":{"status":"missing","reason":"no_offers"},"hospital_nights_median":{"status":"missing","reason":"no_offers"},"days_in_country_median":{"status":"missing","reason":"no_offers"},"top_offers":{"status":"missing","reason":"no_offers"},"packages":{"status":"missing","reason":"no_offers"},"related_packages":{"status":"missing","reason":"no_offers"},"other_packages":{"status":"missing","reason":"no_offers"}},"medical":{"indications":["Early-stage Alzheimer's disease","Mild cognitive impairment with Alzheimer's pathology"],"contraindications":["Active infection","Active or past malignancy","Severe dementia","Bleeding disorders or anticoagulant therapy","Pregnancy or breastfeeding","Severe cardiac, renal or hepatic disease","Immunosuppression","Allergy to product components","Unstable psychiatric or medical condition"],"operation_hours":{"min":2,"max":6,"unit":"hours","qualifier":"Infusion or lumbar puncture plus several hours of post-dose observation per session."},"anesthesia":["none","local"],"sessions_or_stages":{"sessions":{"min":1,"max":3,"unit":"visits","qualifier":"Usually one course of IV or intrathecal doses in one stay; some clinics repeat after 3-6 months."},"stages":[{"code":"assessment_screening","label":"Assessment and screening","after":{"min":0,"max":0,"unit":"days","qualifier":"Done on arrival before treatment."}},{"code":"cell_administration","label":"IV or intrathecal cell administration","after":{"min":1,"max":3,"unit":"days","qualifier":"Doses given within one stay."}},{"code":"repeat_course","label":"Optional repeat course","after":{"min":90,"max":180,"unit":"days","qualifier":"Only if the clinic protocol repeats dosing."}}],"qualifier":"Typical protocol is one course within a single stay."},"hospital_nights":{"value":{"min":2,"max":5,"unit":"nights","qualifier":"Nights until post-dose observation and flight clearance; longer if headache persists."},"source":"parsed_details"},"treatment_conditions":["outpatient"],"rehabilitation_days":{"min":3,"max":7,"unit":"days","qualifier":"Time to ordinary function after administration; cognitive rehabilitation, if used, continues separately."},"fly_home_after_days":{"min":2,"max":5,"unit":"days","qualifier":"After intrathecal dosing, clearance depends on headache resolution and clinician assessment."},"back_to_work_days":{"min":3,"max":7,"unit":"days","qualifier":"Most patients are retired; return to usual activities depends on route and post-procedure headache or fatigue."},"exercise_resume_weeks":{"min":1,"max":2,"unit":"weeks","qualifier":"Light activity resumes first; strenuous exercise waits until puncture-site and symptom resolution."},"final_result_months":{"min":3,"max":12,"unit":"months","qualifier":"Trials assess cognitive outcomes at 3-12 months; no proven effect."},"result_longevity":"No proven benefit or durability has been established. Any reported effect in trials is variable and often transient, with some clinics repeating courses after 3-6 months.","main_risks":["Post-lumbar puncture headache, back pain or low-grade fever","Infection, immune or allergic reactions, and route-related events (intrathecal, intravenous).","Unregulated clinics may use poorly characterized, contaminated or unproven products.","Theoretical abnormal cell growth; not shown in Alzheimer's trials."],"complication_rate_pct":{"min":10,"max":30,"unit":"percent","qualifier":"Any adverse event within 30 days, mostly transient headache, fever, back pain; serious events under 2%"},"revision_rate_pct":{"min":0,"max":0,"unit":"percent","qualifier":"No corrective revision is typical; repeat dosing is counted under sessions or stages."},"success":{"metric":{"status":"missing","reason":"not_collected"},"value":{"status":"missing","reason":"not_collected"},"horizon":{"status":"missing","reason":"not_collected"},"source":{"status":"missing","reason":"not_collected"},"evidence_status":"not_proven"},"scars":"No visible scar; only a small needle puncture mark at the lumbar or IV site. If cells are harvested by liposuction or marrow aspiration, a tiny puncture mark remains.","pain":"Mild and brief: lumbar puncture or IV site discomfort. Post-puncture headache, back pain or low-grade fever can occur for 1-3 days.","preparation":["Neurology review of diagnosis and stage","Baseline MMSE or MoCA testing","Brain MRI or CT review","Blood tests and infection screening","Review and adjust anticoagulants","Medication list reviewed","Caregiver or legal guardian consent"],"recovery_timeline":[{"phase":"Day 0-1","description":"Cell administration followed by observation for reactions, headache or fever.","restrictions":["Lie flat if intrathecal","Avoid driving","Stay hydrated"]},{"phase":"Days 2-7","description":"Mild fatigue or headache may settle; monitoring of neurological status continues.","restrictions":["No strenuous activity","Caregiver supervision"]},{"phase":"Weeks 2-4","description":"Return to normal routine; early follow-up checks.","restrictions":["Report fever, severe headache or new neurological symptoms"]},{"phase":"Months 3-6","description":"Cognitive reassessment to evaluate any change.","restrictions":{"status":"missing","reason":"not_collected"}}],"follow_up_visits":[{"purpose":"wound_check","requirement":"routine","after":{"min":1,"max":7,"unit":"days","qualifier":"Check for headache, fever or puncture-site problems."}},{"purpose":"assessment","requirement":"routine","after":{"min":30,"max":90,"unit":"days","qualifier":"Cognitive testing such as MMSE or MoCA."}},{"purpose":"result_review","requirement":"routine","after":{"min":90,"max":180,"unit":"days","qualifier":"Repeat cognitive testing and possible imaging."}}],"sources":{"status":"missing","reason":"not_collected"},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Check whether the treatment is approved for Alzheimer's disease","scope":"procedure","source":{"url":"https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/consumer-alert-regenerative-medicine-products-including-stem-cells-and-exosomes","host":"fda.gov","quote":"None of these products have been approved to treat any neurological disorder, such as multiple sclerosis, amyotrophic lateral sclerosis (ALS; Lou Gehrig’s disease), Alzheimer’s disease, Parkinson’s disease, epilepsy, or stroke.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C2","text":"Check that the product is offered only within a clinical trial, since charges outside one suggest an illegal product","scope":"treatment_type","source":{"url":"https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/important-patient-and-consumer-information-about-regenerative-medicine-therapies?","host":"fda.gov","quote":"Please know that if you are being charged for these products or offered these products outside of a clinical trial, you are likely being deceived and offered a product illegally.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C3","text":"Check that you understand the entire process and known risks before signing","scope":"treatment_type","source":{"url":"https://www.fda.gov/safety/medical-product-safety-information/public-safety-alert-due-marketing-unapproved-stem-cell-and-exosome-products","host":"fda.gov","quote":"Make sure you understand the entire process and known risks before you sign.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C4","text":"Ask the study sponsor for the clinical investigator's brochure, which covers safety and effectiveness","scope":"treatment_type","source":{"url":"https://www.fda.gov/safety/medical-product-safety-information/public-safety-alert-due-marketing-unapproved-stem-cell-and-exosome-products","host":"fda.gov","quote":"You also can ask the study sponsor for the clinical investigator’s brochure, which includes a short description of the product and information about its safety and effectiveness.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C5","text":"Confirm the surgeon is trained and experienced in the exact procedure you are considering, not just in surgery generally","scope":"treatment_abroad","source":{"url":"https://www.isaps.org/discover/patients-home/considering-your-procedure-abroad/finding-a-surgeon-abroad/","host":"isaps.org","quote":"Verify that the surgeon is trained and experienced in performing the procedure you are considering.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"The offer claims the product treats Alzheimer's disease, though it is not approved for that","scope":"procedure","source":{"url":"https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/important-patient-and-consumer-information-about-regenerative-medicine-therapies?","host":"fda.gov","quote":"Regenerative medicine therapies have not been approved to treat any neurological disorder, such as multiple sclerosis, amyotrophic lateral sclerosis (ALS; Lou Gehrig’s disease), Alzheimer’s disease, Parkinson’s disease, epilepsy, or stroke.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"F2","text":"A clinic charges for the product outside any clinical trial","scope":"treatment_type","source":{"url":"https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/important-patient-and-consumer-information-about-regenerative-medicine-therapies?","host":"fda.gov","quote":"Please know that if you are being charged for these products or offered these products outside of a clinical trial, you are likely being deceived and offered a product illegally.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"F3","text":"Marketing calls the product safe and effective though it lacks adequate study","scope":"treatment_type","source":{"url":"https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/important-patient-and-consumer-information-about-regenerative-medicine-therapies?","host":"fda.gov","quote":"These regenerative medicine products have risks but are often illegally marketed by clinics as being safe and effective for the treatment of a wide range of diseases or conditions, even though they haven’t been adequately studied under an IND to demonstrate the claims of safety and effectiveness.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"F4","text":"The provider asks you to sign before explaining the process and known risks","scope":"treatment_type","source":{"url":"https://www.fda.gov/safety/medical-product-safety-information/public-safety-alert-due-marketing-unapproved-stem-cell-and-exosome-products","host":"fda.gov","quote":"Make sure you understand the entire process and known risks before you sign.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"warning_signs":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-13","next_check_at":"2027-02-11"},"take_home":{"status":"ok","items":[{"id":"T1","text":"Home doctor needs the clinic's follow-up recommendations in a written discharge summary","document":"discharge summary","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"When you have treatment abroad, you must ask the treatment provider for their follow-up recommendations documented within a written discharge summary in English.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T2","text":"Ask for copies of all prescriptions before you leave","document":"prescription copies","source":{"url":"https://travelhealthpro.org.uk/news/699/travelling-abroad-for-treatment","host":"travelhealthpro.org.uk","quote":"Remember to ask for copies of all your treatment records, including prescriptions, scans and x-rays before you leave.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T3","text":"Home doctor needs the dates for required blood tests and follow-up appointments","document":"written aftercare plan","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"This should include any medication and doses, as well as any dates that blood tests and follow-up appointments must be carried out.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1}},"parsed_details":{"procedure_type":"therapy","fields":{"anesthesia":["none","local"],"back_to_work_days":{"min":3,"max":7,"unit":"days","qualifier":"Most patients are retired; return to usual activities depends on route and post-procedure headache or fatigue."},"complication_rate_pct":{"min":10,"max":30,"unit":"percent","qualifier":"Any adverse event within 30 days, mostly transient headache, fever, back pain; serious events under 2%"},"contraindications":["Active infection","Active or past malignancy","Severe dementia","Bleeding disorders or anticoagulant therapy","Pregnancy or breastfeeding","Severe cardiac, renal or hepatic disease","Immunosuppression","Allergy to product components","Unstable psychiatric or medical condition"],"days_in_clinic":{"min":2,"max":5,"unit":"nights","qualifier":"Nights until post-dose observation and flight clearance; longer if headache persists."},"diagnostic_duration_minutes":null,"diagnostic_preparation":null,"diagnostic_referral_needed":null,"diagnostic_result_time_hours":null,"exercise_resume_weeks":{"min":1,"max":2,"unit":"weeks","qualifier":"Light activity resumes first; strenuous exercise waits until puncture-site and symptom resolution."},"final_result_months":{"min":3,"max":12,"unit":"months","qualifier":"Trials assess cognitive outcomes at 3-12 months; no proven effect."},"fly_home_after_days":{"min":2,"max":5,"unit":"days","qualifier":"After intrathecal dosing, clearance depends on headache resolution and clinician assessment."},"follow_up_visits":[{"purpose":"wound_check","after":{"min":1,"max":7,"unit":"days","qualifier":"Check for headache, fever or puncture-site problems."},"requirement":"routine"},{"purpose":"assessment","after":{"min":30,"max":90,"unit":"days","qualifier":"Cognitive testing such as MMSE or MoCA."},"requirement":"routine"},{"purpose":"result_review","after":{"min":90,"max":180,"unit":"days","qualifier":"Repeat cognitive testing and possible imaging."},"requirement":"routine"}],"indications":["Early-stage Alzheimer's disease","Mild cognitive impairment with Alzheimer's pathology"],"main_risks":["Post-lumbar puncture headache, back pain or low-grade fever","Infection, immune or allergic reactions, and route-related events (intrathecal, intravenous).","Unregulated clinics may use poorly characterized, contaminated or unproven products.","Theoretical abnormal cell growth; not shown in Alzheimer's trials."],"pain":"Mild and brief: lumbar puncture or IV site discomfort. Post-puncture headache, back pain or low-grade fever can occur for 1-3 days.","preparation":["Neurology review of diagnosis and stage","Baseline MMSE or MoCA testing","Brain MRI or CT review","Blood tests and infection screening","Review and adjust anticoagulants","Medication list reviewed","Caregiver or legal guardian consent"],"recovery_timeline":[{"phase":"Day 0-1","description":"Cell administration followed by observation for reactions, headache or fever.","restrictions":["Lie flat if intrathecal","Avoid driving","Stay hydrated"]},{"phase":"Days 2-7","description":"Mild fatigue or headache may settle; monitoring of neurological status continues.","restrictions":["No strenuous activity","Caregiver supervision"]},{"phase":"Weeks 2-4","description":"Return to normal routine; early follow-up checks.","restrictions":["Report fever, severe headache or new neurological symptoms"]},{"phase":"Months 3-6","description":"Cognitive reassessment to evaluate any change.","restrictions":[]}],"rehabilitation_days":{"min":3,"max":7,"unit":"days","qualifier":"Time to ordinary function after administration; cognitive rehabilitation, if used, continues separately."},"result_longevity":"No proven benefit or durability has been established. Any reported effect in trials is variable and often transient, with some clinics repeating courses after 3-6 months.","revision_rate_pct":{"min":0,"max":0,"unit":"percent","qualifier":"No corrective revision is typical; repeat dosing is counted under sessions or stages."},"scars":"No visible scar; only a small needle puncture mark at the lumbar or IV site. If cells are harvested by liposuction or marrow aspiration, a tiny puncture mark remains.","sessions_or_stages":{"sessions":{"min":1,"max":3,"unit":"visits","qualifier":"Usually one course of IV or intrathecal doses in one stay; some clinics repeat after 3-6 months."},"stages":[{"code":"assessment_screening","label":"Assessment and screening","after":{"min":0,"max":0,"unit":"days","qualifier":"Done on arrival before treatment."}},{"code":"cell_administration","label":"IV or intrathecal cell administration","after":{"min":1,"max":3,"unit":"days","qualifier":"Doses given within one stay."}},{"code":"repeat_course","label":"Optional repeat course","after":{"min":90,"max":180,"unit":"days","qualifier":"Only if the clinic protocol repeats dosing."}}],"qualifier":"Typical protocol is one course within a single stay."},"success":{"metric":null,"value":null,"unit":null,"horizon":null,"population":"Adults with mild Alzheimer's or mild cognitive impairment in small early-phase trials","evidence_status":"not_proven"},"techniques":[{"name":"Intravenous mesenchymal stem cell infusion","suits_whom":"Early-stage or mild cognitive impairment patients preferring a less invasive route.","recovery":"Same-day discharge; mild fever or fatigue for 1-2 days."},{"name":"Intrathecal stem cell injection","suits_whom":"Patients in trials seeking direct delivery to cerebrospinal fluid.","recovery":"Rest 24 hours; possible headache for 1-3 days."},{"name":"Intranasal stem cell delivery","suits_whom":"Experimental option for mild disease avoiding needles.","recovery":"No downtime; minimal local irritation."}],"treatment_conditions":["outpatient"],"treatment_duration_hours":{"min":2,"max":6,"unit":"hours","qualifier":"Infusion or lumbar puncture plus several hours of post-dose observation per session."},"initial_assessment_documents":["Neurologist report with Alzheimer's diagnosis","Brain MRI or CT report","MMSE or MoCA cognitive test results","Amyloid or tau PET report (if available)","Recent blood tests with infection screening","List of current dementia medications"],"travel_trips":{"min":1,"max":1,"one_trip_possible":true,"qualifier":"One trip covers the single-stay course; repeat courses need extra trips."},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Check whether the treatment is approved for Alzheimer's disease","scope":"procedure","source":{"url":"https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/consumer-alert-regenerative-medicine-products-including-stem-cells-and-exosomes","host":"fda.gov","quote":"None of these products have been approved to treat any neurological disorder, such as multiple sclerosis, amyotrophic lateral sclerosis (ALS; Lou Gehrig’s disease), Alzheimer’s disease, Parkinson’s disease, epilepsy, or stroke.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C2","text":"Check that the product is offered only within a clinical trial, since charges outside one suggest an illegal product","scope":"treatment_type","source":{"url":"https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/important-patient-and-consumer-information-about-regenerative-medicine-therapies?","host":"fda.gov","quote":"Please know that if you are being charged for these products or offered these products outside of a clinical trial, you are likely being deceived and offered a product illegally.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C3","text":"Check that you understand the entire process and known risks before signing","scope":"treatment_type","source":{"url":"https://www.fda.gov/safety/medical-product-safety-information/public-safety-alert-due-marketing-unapproved-stem-cell-and-exosome-products","host":"fda.gov","quote":"Make sure you understand the entire process and known risks before you sign.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C4","text":"Ask the study sponsor for the clinical investigator's brochure, which covers safety and effectiveness","scope":"treatment_type","source":{"url":"https://www.fda.gov/safety/medical-product-safety-information/public-safety-alert-due-marketing-unapproved-stem-cell-and-exosome-products","host":"fda.gov","quote":"You also can ask the study sponsor for the clinical investigator’s brochure, which includes a short description of the product and information about its safety and effectiveness.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C5","text":"Confirm the surgeon is trained and experienced in the exact procedure you are considering, not just in surgery generally","scope":"treatment_abroad","source":{"url":"https://www.isaps.org/discover/patients-home/considering-your-procedure-abroad/finding-a-surgeon-abroad/","host":"isaps.org","quote":"Verify that the surgeon is trained and experienced in performing the procedure you are considering.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"The offer claims the product treats Alzheimer's disease, though it is not approved for that","scope":"procedure","source":{"url":"https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/important-patient-and-consumer-information-about-regenerative-medicine-therapies?","host":"fda.gov","quote":"Regenerative medicine therapies have not been approved to treat any neurological disorder, such as multiple sclerosis, amyotrophic lateral sclerosis (ALS; Lou Gehrig’s disease), Alzheimer’s disease, Parkinson’s disease, epilepsy, or stroke.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"F2","text":"A clinic charges for the product outside any clinical trial","scope":"treatment_type","source":{"url":"https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/important-patient-and-consumer-information-about-regenerative-medicine-therapies?","host":"fda.gov","quote":"Please know that if you are being charged for these products or offered these products outside of a clinical trial, you are likely being deceived and offered a product illegally.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"F3","text":"Marketing calls the product safe and effective though it lacks adequate study","scope":"treatment_type","source":{"url":"https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/important-patient-and-consumer-information-about-regenerative-medicine-therapies?","host":"fda.gov","quote":"These regenerative medicine products have risks but are often illegally marketed by clinics as being safe and effective for the treatment of a wide range of diseases or conditions, even though they haven’t been adequately studied under an IND to demonstrate the claims of safety and effectiveness.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"F4","text":"The provider asks you to sign before explaining the process and known risks","scope":"treatment_type","source":{"url":"https://www.fda.gov/safety/medical-product-safety-information/public-safety-alert-due-marketing-unapproved-stem-cell-and-exosome-products","host":"fda.gov","quote":"Make sure you understand the entire process and known risks before you sign.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"warning_signs":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-13","next_check_at":"2027-02-11"},"take_home":{"status":"ok","items":[{"id":"T1","text":"Home doctor needs the clinic's follow-up recommendations in a written discharge summary","document":"discharge summary","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"When you have treatment abroad, you must ask the treatment provider for their follow-up recommendations documented within a written discharge summary in English.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T2","text":"Ask for copies of all prescriptions before you leave","document":"prescription copies","source":{"url":"https://travelhealthpro.org.uk/news/699/travelling-abroad-for-treatment","host":"travelhealthpro.org.uk","quote":"Remember to ask for copies of all your treatment records, including prescriptions, scans and x-rays before you leave.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T3","text":"Home doctor needs the dates for required blood tests and follow-up appointments","document":"written aftercare plan","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"This should include any medication and doses, as well as any dates that blood tests and follow-up appointments must be carried out.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"alternatives":{"status":"ok","items":[{"id":"A1","text":"You can receive regular intravenous infusion treatment","name":"Lecanemab","source":{"url":"https://my.clevelandclinic.org/health/diseases/9164-alzheimers-disease","host":"my.clevelandclinic.org","quote":"Lecanemab and donanemab are intravenous (IV) infusions.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200},"operation_id":null},{"id":"A2","text":"You have early Alzheimer’s disease","name":"Donanemab","source":{"url":"https://www.nia.nih.gov/health/alzheimers-treatment/how-alzheimers-disease-treated","host":"nia.nih.gov","quote":"Lecanemab and donanemab are FDA-approved immunotherapy drugs for the treatment of early Alzheimer’s.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200},"operation_id":null}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"technique_details":{"status":"ok","items":[{"id":"intravenous-mesenchymal-stem","name":"Intravenous mesenchymal stem cell infusion","how_it_works":{"text":"Stem cells are given through an injection into a vein","source":{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12067764/","host":"pmc.ncbi.nlm.nih.gov","quote":"Administration routes varied, with stereotactic and intravenous injections targeting affected brain regions.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}},{"id":"intrathecal-stem-cell","name":"Intrathecal stem cell injection","how_it_works":{"text":"Cells enter cerebrospinal fluid and bypass the blood-brain barrier","source":{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12467120","host":"ncbi.nlm.nih.gov","quote":"Intrathecal (IT) administration of therapeutics directly into the cerebrospinal fluid (CSF) bypasses the BBB, offering a promising avenue for antisense oligonucleotides (ASOs), gene therapies, antibodies, and stem cells for these disorders.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":429}},"recovery_daily":{"status":"missing","reason":"no_official_source"}},{"id":"intranasal-stem-cell","name":"Intranasal stem cell delivery","how_it_works":{"text":"Cells travel through the nasal route toward the brain","source":{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879630/","host":"ncbi.nlm.nih.gov","quote":"The intranasal route is a noninvasive and convenient way that can easily and repeatedly deliver drugs, exosomes, and stem cells to the brain.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1}}},"techniques":[{"id":"intravenous-mesenchymal-stem","name":"Intravenous mesenchymal stem cell infusion","how_it_works":{"id":"H1","text":"Stem cells are given through an injection into a vein","source":{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12067764/","host":"pmc.ncbi.nlm.nih.gov","quote":"Administration routes varied, with stereotactic and intravenous injections targeting affected brain regions.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Early-stage or mild cognitive impairment patients preferring a less invasive route.","price_from":{"status":"missing","reason":"not_collected"},"recovery":"Same-day discharge; mild fever or fatigue for 1-2 days."},{"id":"intrathecal-stem-cell","name":"Intrathecal stem cell injection","how_it_works":{"id":"H1","text":"Cells enter cerebrospinal fluid and bypass the blood-brain barrier","source":{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12467120","host":"ncbi.nlm.nih.gov","quote":"Intrathecal (IT) administration of therapeutics directly into the cerebrospinal fluid (CSF) bypasses the BBB, offering a promising avenue for antisense oligonucleotides (ASOs), gene therapies, antibodies, and stem cells for these disorders.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":429}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Patients in trials seeking direct delivery to cerebrospinal fluid.","price_from":{"status":"missing","reason":"not_collected"},"recovery":"Rest 24 hours; possible headache for 1-3 days."},{"id":"intranasal-stem-cell","name":"Intranasal stem cell delivery","how_it_works":{"id":"H1","text":"Cells travel through the nasal route toward the brain","source":{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879630/","host":"ncbi.nlm.nih.gov","quote":"The intranasal route is a noninvasive and convenient way that can easily and repeatedly deliver drugs, exosomes, and stem cells to the brain.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Experimental option for mild disease avoiding needles.","price_from":{"status":"missing","reason":"not_collected"},"recovery":"No downtime; minimal local irritation."}],"alternatives":{"status":"ok","items":[{"id":"A1","text":"You can receive regular intravenous infusion treatment","name":"Lecanemab","source":{"url":"https://my.clevelandclinic.org/health/diseases/9164-alzheimers-disease","host":"my.clevelandclinic.org","quote":"Lecanemab and donanemab are intravenous (IV) infusions.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200},"operation_id":null},{"id":"A2","text":"You have early Alzheimer’s disease","name":"Donanemab","source":{"url":"https://www.nia.nih.gov/health/alzheimers-treatment/how-alzheimers-disease-treated","host":"nia.nih.gov","quote":"Lecanemab and donanemab are FDA-approved immunotherapy drugs for the treatment of early Alzheimer’s.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200},"operation_id":null}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"diagnostic":{"status":"not_applicable"},"country":{"why":{"status":"ok","items":[{"id":"Y1","text":"Turkey's Ministry of Health publishes lists of authorized healthcare providers and facilitators holding authorization certificates","specialties":[],"source":{"url":"https://shgmturizmdb.saglik.gov.tr/EN-69410/announcements.html","host":"shgmturizmdb.saglik.gov.tr","quote":"Updated lists of healthcare providers and facilitators that have been granted authorization certificates by the Ministry","tier":"government","fetched_at":"2026-11-12","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-05-11","version":1},"travel":{"status":"ok","items":[{"id":"V1","item":"visa","audience":"uk","volatile":true,"text":"UK citizen passport holders can visit Turkey without a visa for up to 90 days in any 180-day period, for business or tourism","source":{"url":"https://www.gov.uk/foreign-travel-advice/turkey/entry-requirements","host":"gov.uk","quote":"You can visit Turkey without a visa for up to 90 days in any 180-day period, for business or tourism.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V2","item":"visa","audience":"us","volatile":true,"text":"US ordinary passport holders are exempt from a visa for up to 90 days in any 180-day period in Turkey","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Turkey.html","host":"travel.state.gov","quote":"Ordinary passport holders are exempted from visa up to 90 days in any 180-day period.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V3","item":"passport_validity","audience":"uk","volatile":true,"text":"A UK passport must expire at least 150 days after arrival in Turkey and have at least 1 blank page","source":{"url":"https://www.gov.uk/foreign-travel-advice/turkey/entry-requirements","host":"gov.uk","quote":"To enter Turkey, your passport must have an ‘expiry date’ at least 150 days after the date you arrive and at least 1 blank page.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V4","item":"passport_validity","audience":"us","volatile":true,"text":"A US passport must be valid for six months beyond the entry date into Turkey","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Turkey.html","host":"travel.state.gov","quote":"Passports must be valid for six months beyond your entry date.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V5","item":"prescriptions","audience":"uk","volatile":false,"text":"British prescriptions are not accepted in pharmacies in Turkey","source":{"url":"https://www.gov.uk/foreign-travel-advice/turkey/health","host":"gov.uk","quote":"British prescriptions are not accepted in pharmacies in Turkey.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V6","item":"emergency_number","audience":"all","volatile":false,"text":"Dial 112 and ask for an ambulance in Turkey","source":{"url":"https://www.gov.uk/foreign-travel-advice/turkey/health","host":"gov.uk","quote":"Dial 112 and ask for an ambulance.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-11","next_check_at":"2026-12-11","version":1},"other_countries_with_page":["china","colombia","india","italy","japan","mexico","republic-of-korea","spain","thailand","ukraine"]},"often_combined_with":{"status":"missing","reason":"not_collected"},"reviews":{"avg_rating":4.59,"count":603,"scope":"clinic","rating_scale":5,"pros":{"status":"missing","reason":"not_collected"},"cons":{"status":"missing","reason":"not_collected"}},"current":{"seo_text":"<p>Stem cell therapy for Alzheimer's disease in Turkey typically costs from _op_1430_price_from_ to _op_1430_price_to_. Final prices depend on the cell source, the number of sessions, and the clinic's specialized technology. In the US, similar protocols cost around _price_compare_US_average_ on average. Patients in Turkey save approximately _price_percent_discount_%, which usually covers medical consultations, diagnostic MRIs, mesenchymal stem cell applications, and VIP logistical support.</p>\n\n<ul>\n<li><strong>Multi-dose protocols:</strong> Higher costs apply for treatments involving three doses compared to two-dose cycles.</li>\n<li><strong>Cell processing standards:</strong> Labs using Good Manufacturing Practice (GMP) certified facilities often command a premium.</li>\n<li><strong>Medical hub location:</strong> Istanbul and Antalya serve as the primary destinations for regenerative medicine.</li>\n<li><strong>Diagnostic inclusions:</strong> Premium packages frequently bundle biochemical blood analysis and post-procedure nutritional support.</li>\n</ul>\n\n<p><strong>Bookimed Expert Insight:</strong> Choosing a clinic with an integrated GMP-standard laboratory provides the best therapeutic value. Liv Hospital Ulus stands out as it houses Turkey's first private institutional stem cell center. Their premium packages, starting around $21,000, include 16 days of hotel accommodation and specialized vitamin infusions. This extended stay ensures better monitoring compared to basic outpatient protocols. Dr. Erdal Karaöz, with over 38 years of experience, leads these Ministry-approved clinical trials. This level of verification offers significant peace of mind for families navigating complex neurological care.</p>","faq":[{"q":"Can stem cell therapy cure Alzheimer's disease?","a":"<p>Stem cell therapy cannot cure Alzheimers disease as it remains in experimental stages. While clinical trials show the treatment is generally safe, no regulatory agency has approved it to reverse the condition. Research focuses on using mesenchymal stem cells to reduce brain inflammation rather than replacing lost neurons.</p> <ul> <li><strong>Current status:</strong> Therapy is experimental and not FDA-approved for widespread medical use.</li> <li><strong>Primary goal:</strong> MSCs aim to lower inflammation and clear amyloid-beta plaques.</li> <li><strong>Clinical evidence:</strong> Human trials show safety but inconsistent results in stopping disease progression.</li> <li><strong>Delivery methods:</strong> Turkish clinics utilize intravenous infusion and intrathecal injections for cell delivery.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Documentation matters more than marketing for this procedure. Leading centers like Liv Hospital Ulus use internal GMP-standard laboratories to ensure cell quality. Patients should verify if the facility has Turkish Ministry of Health approval for specific clinical trials. High-quality packages often include 16 days of hotel stay to monitor the post-therapy adaptation phase.</p> <p><strong>Patient Consensus:</strong> Many families describe seeking treatment as buying hope. While some report brief cognitive improvements, these often fade within six months without sustained long-term changes.</p>"},{"q":"What type of stem cells are used?","a":"<p>Stem cell therapy for Alzheimer's in Turkey primarily utilizes allogeneic mesenchymal stem cells derived from umbilical cord tissue, known as Wharton's jelly. These GMP-produced cells are often administered intrathecally or intravenously to target neuroinflammation and support potential neural tissue regeneration in JCI-accredited facilities.</p> <ul> <li><strong>Cell source:</strong> Most clinics use allogeneic mesenchymal stem cells from umbilical cord tissue.</li> <li><strong>Production standard:</strong> Cells are processed in specialized Good Manufacturing Practice (GMP) certified laboratories.</li> <li><strong>Delivery method:</strong> Administration typically involves intrathecal injections or intravenous infusions over multiple doses.</li> <li><strong>Enhancement options:</strong> Some advanced protocols include exosome-enhanced mesenchymal cells for better blood-brain barrier penetration.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Data from Liv Hospital Ulus shows a transition toward using only GMP-produced cells from Turkey's first private hospital stem cell center. While many expect autologous cells, clinics here favor umbilical cord-derived MSCs because these donor cells are often more potent and biologically active than a patient's own aged cells.</p> <p><strong>Patient Consensus:</strong> Patients often note that clinics may suggest switching from autologous to donor cells for higher potency. Many emphasize the importance of following a strict neuroplasticity-focused protocol, including nutritional support, alongside the cell injections.</p>"},{"q":"Is the procedure safe for elderly patients?","a":"<p>Stem cell therapy for Alzheimer's in Turkey is generally considered safe for elderly patients when performed in JCI-accredited facilities. Using minimally invasive intravenous or intrathecal injections avoids the high risks of general anesthesia or major surgery. Specialized centers utilize GMP-certified mesenchymal stem cells to ensure biological safety and reduce inflammatory responses.</p> <ul> <li><strong>Anesthesia protocol:</strong> Minimally invasive injections often require only local anesthesia to protect sensitive cardiac systems.</li> <li><strong>Hospital stay:</strong> Professional packages include 2 days of hospitalization for immediate post-procedure neurological monitoring.</li> <li><strong>Recovery support:</strong> Extended 16-day hotel stays allow for essential follow-up visits before international travel.</li> <li><strong>Expert oversight:</strong> Surgeons like Erdal Karaöz at Liv Hospital Ulus manage Turkey first private GMP center.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While many search for the lowest cost, the 16-night hotel inclusion at clinics like Liv Hospital Ulus is a critical safety differentiator. This extended period ensures elderly patients stabilize after cellular therapy before enduring the physiological stress of a long-haul flight home.</p> <p><strong>Patient Consensus:</strong> Families emphasize securing medical clearance from a home cardiologist before traveling. They also stress ensuring consent forms and procedure risks are explained clearly in the patient native language.</p>"},{"q":"How long does it take to see results?","a":"<p>Patients typically observe subtle cognitive improvements 3 to 6 months after stem cell therapy for Alzheimer's in Turkey. Peak regenerative effects generally manifest around 12 months post-injection, as mesenchymal stem cells work to reduce neuroinflammation and support neural repair protocols within JCI-accredited facilities.</p> <ul> <li><strong>Initial changes:</strong> Subtle cognitive shifts or mood stabilization often appear within 3–6 months.</li> <li><strong>Peak response:</strong> Maximum therapeutic benefits are typically reported at the 12-month mark.</li> <li><strong>Paradoxical phase:</strong> Temporary brain fog may occur during the first 1–3 months post-infusion.</li> <li><strong>Duration of effect:</strong> Results are incremental, with some patients requiring repeat assessments after 1 year.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Data from Liv Hospital Ulus shows that combining GMP-standard stem cells with 16-night recovery stays optimizes monitoring. Prof. Erdal Karaöz uses multi-dose protocols because repeated exposure often yields more consistent neurological stabilization than a single infusion. This structured approach helps manage the initial inflammatory phase effectively.</p> <p><strong>Patient Consensus:</strong> Patients emphasize that gains like remembering names or improved mood are gradual. Real-world experiences suggest using objective tools like MoCA scores to track these subtle improvements rather than relying on daily impressions.</p>"},{"q":"Which clinics are recognized for stem-cell Alzheimer’s therapy in Turkey?","a":"<p>Top Turkish clinics for Alzheimer’s stem cell therapy include JCI-accredited facilities like Liv Hospital Ulus and Memorial Şişli Hospital. These centers utilize mesenchymal stem cells (MSCs) and Good Manufacturing Practice (GMP) certified laboratories to provide regenerative treatments under specialized neurological protocols in Istanbul.</p> <ul> <li><strong>Liv Hospital Ulus:</strong> Features Turkey’s first private-hospital GMP stem cell center led by Professor Erdal Karaöz.</li> <li><strong>Memorial Şişli Hospital:</strong> First JCI-accredited hospital in Turkey offering multi-disciplinary neurology and regenerative care.</li> <li><strong>Treatment protocols:</strong> Standard packages include 2 to 3 doses of allogeneic mesenchymal stem cells.</li> <li><strong>Ancillary services:</strong> Premium packages frequently bundle 16-night hotel stays, VIP transfers, and specialist consultations.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While many clinics offer single-dose treatments, the most established Turkish programs like Liv Hospital Ulus emphasize multi-dose protocols (up to 3 doses) paired with extended 16-day recovery stays. This long-term monitoring approach is a significant differentiator compared to standard outpatient infusions seen in other regions.</p> <p><strong>Patient Consensus:</strong> Patients emphasize the importance of tracking MoCA scores and consulting independent neurologists, as these therapies are currently considered palliative and outcomes vary significantly between cases.</p>"},{"q":"Who are the leading specialists delivering this therapy?","a":"<p>Leading specialists for Alzheimer's stem cell therapy in Turkey include cellular therapy researchers and neurosurgeons operating in GMP-standard facilities. Key figures like Professor Erdal Karaoz at Liv Hospital Ulus and Associate Professor Necati Kaplan lead clinical trials using mesenchymal stem cells processed in specialized laboratory environments.</p> <ul> <li><strong>Professor Erdal Karaoz:</strong> Leads Turkey’s first private GMP-standard stem cell center at Liv Hospital Ulus.</li> <li><strong>Associate Professor Necati Kaplan:</strong> Performed 60,000+ operations; researches allogeneic mesenchymal stem cells for brain trauma.</li> <li><strong>Professor Halil Can:</strong> Specialist at Istinye University focused on epilepsy and functional neurosurgery applications.</li> <li><strong>Dr. Selcuk Duman:</strong> Directs cellular technologies at Rumi Pulse with 40 years of processing experience.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While many neurosurgeons offer stem cell infusions, the most advanced results come from specialists who control their own laboratory environments. Professor Erdal Karaoz at Liv Hospital Ulus manages one of the few clinics with an integrated GMP lab, ensuring cell viability and precise 2-to-3 dose protocols that are rarely matched by smaller outpatient centers.</p> <p><strong>Patient Consensus:</strong> Families emphasize targeting credible researchers like Professor Erdal Karaoz but warn that cognitive improvements may be temporary. Many advise coordinating with a home neurologist to monitor memory scores and setting realistic expectations for short-term clarity rather than a permanent cure.</p>"},{"q":"What are typical accommodation costs for medical travelers in Istanbul?","a":"<p>Medical travelers in Istanbul typically spend $50 to $150 per night for standard hotels, while high-end recovery environments range from $160 to $200. Many clinics, particularly for stem cell therapy, bundle 16 days of hotel stay into premium packages to ensure proper post-treatment monitoring.</p> <ul> <li><strong>Budget stay:</strong> Private rooms in guesthouses like Fatih cost $20 to $40 per night.</li> <li><strong>Mid-range hotel:</strong> Reliable 3-star and 4-star options average between $50 and $115 nightly.</li> <li><strong>Serviced apartment:</strong> Self-catering units for long-term recovery cost approximately $43 to $60 per day.</li> <li><strong>Hospital companion:</strong> Private facilities like Emsey Hospital charge around $100 daily for companion stays.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While daily rates seem low, stem cell therapy often requires 16-day recovery windows. Choosing premium packages at centers like Liv Hospital Ulus is more cost-effective because they include the full 16-night hotel stay and VIP transfers, which would otherwise add $1,200 to $2,000 to your independent travel budget.</p> <p><strong>Patient Consensus:</strong> Travelers suggest booking apartments with kitchens in Şişli or Nişantaşı to save 50% compared to hotels. Many advise negotiating 20–30% discounts directly with hosts for stays exceeding two weeks.</p>"}],"h2":[{"text":"Как это работает","kind":"content"},{"text":"Какая цена лечения болезни альцгеймера стволовыми клетками в Турции?","kind":"content"},{"text":"Лучшие клиники по лечению болезни Альцгеймера стволовыми клетками в Турции — 5 проверенных вариантов с ценами","kind":"content"},{"text":"Обзор процедуры Лечение болезни Альцгеймера стволовыми клетками в Турции","kind":"content"},{"text":"Лучшие специалисты по лечению болезни Альцгеймера стволовыми клетками в Турции — 6 докторов с отзывами и ценами","kind":"content"},{"text":"Видеоистории пациентов Bookimed","kind":"content"},{"text":"Отзывы о Bookimed: узнайте о реальном опыте пациентов","kind":"content"},{"text":"Поделитесь этим материалом","kind":"content"},{"text":"FAQ по лечению болезни Альцгеймера стволовыми клетками в Турции","kind":"content"},{"text":"Получить бесплатную консультацию","kind":"content"}]},"placeholders":{"price_from":"{{price_from}}","clinics_count":"{{clinics_count}}","cities_count":"{{cities_count}}","savings_pct":"{{savings_pct}}","data_date":"{{data_date}}"},"legal":{"restricted_markets":{"status":"missing","reason":"not_collected"}},"conflicts":[]}